Related Experiment Video
Updated: Apr 11, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression
Jianting Long1, Caiwen Ou2, Haoming Xia3
1Department of Medicinal Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.
Abstract:
Breast cancer is one of the most common malignancies and a major cause of cancer-related mortality all over the world. A growing body of reports revealed that microRNAs play essential roles in the progression of cancers. Aberrant expression of miR-503 has been reported in several kinds of cancer. The aim of the current study was to elucidate the role of miR-503 in the pathogenesis of breast cancer. In the present study, our results suggested that miR-503 expression was markedly downregulated in breast cancer tissues and cells. Overexpression of miR-503 in breast cancer cell lines reduced cell proliferation through inducing G0/G1 cell cycle arrest by targeting CCND1. Together, our findings provide new knowledge regarding the role of miR-503 in the progression of breast cancer and indicate the role of miR-503 as a tumor suppressor microRNA (miRNA) in breast cancer.
Insights
MicroRNA-503 (miR-503) is downregulated in breast cancer. Restoring miR-503 suppresses tumor growth by halting cell cycle progression, identifying it as a potential tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading cause of cancer mortality globally.
- MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development.
- Aberrant expression of miR-503 is implicated in various cancers.
Purpose of the Study:
- To investigate the role of miR-503 in the pathogenesis of breast cancer.
- To determine if miR-503 functions as a tumor suppressor in breast cancer.
Main Methods:
- Analysis of miR-503 expression levels in breast cancer tissues and cells.
- Overexpression of miR-503 in breast cancer cell lines.
- Assessment of cell proliferation and cell cycle distribution.
- Identification of miR-503 target genes.
Main Results:
- miR-503 expression was significantly downregulated in breast cancer tissues and cells compared to normal controls.
- Overexpression of miR-503 inhibited breast cancer cell proliferation.
- miR-503 induced G0/G1 cell cycle arrest.
- CCND1 was identified as a direct target of miR-503.
Conclusions:
- miR-503 acts as a tumor suppressor in breast cancer.
- Downregulation of miR-503 contributes to breast cancer progression.
- miR-503 may serve as a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle
Abnormal Proliferation

